GGrantIndex
Sort

23,748 grants matching melanoma

Role of KMT2D and aberrant enhancers in modulating tumor microenvironment in melanoma

$355,019
Kunal Rai · University Of Tx Md Anderson Can Ctr · R01 · FY2019 · CA

Merkel cell polyomavirus infection, DNA damage response and cancer

$355,019
Jianxin You · University Of Pennsylvania · R01 · FY2019 · CA

Amnis ImageStream Cell Analysis System

$355,000
Patricia Fitzgerald-Bocarsly · Univ Of Med/Dent Of Nj-Nj Medical School · S10 · FY2007 · RR

CONCEPT SBIR - T-CELL RECEPTORS FOR TREATING PEDIATRIC ACUTE MYELOID LEUKEMIA

$355,000
Binbin Chen · Vcreate, Inc. · N43 · FY2024 · CA

Antigen-specific T cells in immunotherapy-associated acute kidney injury

$354,960
Naoka Murakami · Brigham And Women'S Hospital · R01 · FY2024 · DK

Role and mechanisms of IGF2BP1 in melanoma pathogenesis

$354,914
Vladimir S. Spiegelman · Pennsylvania State Univ Hershey Med Ctr · R01 · FY2022 · CA

Role and mechanisms of IGF2BP1 in melanoma pathogenesis

$354,914
Vladimir S. Spiegelman · Pennsylvania State Univ Hershey Med Ctr · R01 · FY2023 · CA

CD91 and cancer immunosurveillance

$354,892
Robert J Binder · University Of Pittsburgh At Pittsburgh · R01 · FY2021 · CA

CD91 and cancer immunosurveillance

$354,892
Robert J Binder · University Of Pittsburgh At Pittsburgh · R01 · FY2020 · CA

MECHANOSURVEILLANCE IN BREAST CANCER METASTASIS

$354,889
Ekrem Emrah Er · University Of Illinois At Chicago · R37 · FY2023 · CA

Research Project 1 - Targeting the MAPK and PI3K pathways in melanoma PDX

$354,878
Meenhard Herlyn · Wistar Institute · U54 · FY2019 · CA

Addressing Urban Rural Disparities in Cancer: The Case for Registry Expansion

$354,862
Cathy J. Bradley · University Of Colorado Denver · R01 · FY2022 · CA

Treating CNS malignancies with 131-I-8H9

$354,861
Kim Kramer · Sloan-Kettering Inst Can Research · R21 · FY2006 · CA

Access, Utilization and Outcomes of Cancer Services in the Era of Telemedicine

$354,662
Tracy Onega · University Of Utah · R01 · FY2023 · CA

Cancer and Leukemia Group B: RPCI/SUNYAB

$354,626
Roswell Park Cancer Institute Corp · U10 · FY2004 · CA

Prevention of skin cancer by phytochemicals via Nrf2 and epigenetics

$354,563
Ah-Ng Tony Kong · Rutgers, The State Univ Of N.J. · R01 · FY2020 · CA

Prevention of skin cancer by phytochemicals via Nrf2 and epigenetics

$354,563
Ah-Ng Tony Kong · Rutgers, The State Univ Of N.J. · R01 · FY2017 · CA

Prevention of skin cancer by phytochemicals via Nrf2 and epigenetics

$354,563
Ah-Ng Tony Kong · Rutgers, The State Univ Of N.J. · R01 · FY2018 · CA

PHOTODYNAMIC THERAPY (PDT) AND TUMOR IMMUNITY

$354,563
Sandra O Gollnick · Roswell Park Cancer Institute Corp · R01 · FY2010 · CA

Development of a targeted delivery platform for checkpoint inhibitors

$354,563
Kun Cheng · University Of Missouri Kansas City · R01 · FY2021 · CA

Mechanistic study on synergistic photo-immunological effects of laser immunotherapy for metastatic cancers

$354,563
Wei R. Chen · University Of Oklahoma · R01 · FY2021 · CA

Development of a targeted delivery platform for checkpoint inhibitors

$354,563
Kun Cheng · University Of Missouri Kansas City · R01 · FY2018 · CA

Development of a targeted delivery platform for checkpoint inhibitors

$354,563
Kun Cheng · University Of Missouri Kansas City · R01 · FY2020 · CA

Quantitative Adductomics Approaches for Assessing the Occurrence and Repair of DNA Adducts

$354,563
Yinsheng Wang · University Of California Riverside · R01 · FY2017 · CA

Discovery of small molecule inhibitors for protein N-terminal methyltransferase

$354,563
Rong Huang · Purdue University · U01 · FY2017 · CA